已收盘 07-02 16:00:00 美东时间
+0.001
+0.30%
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Beyond Air业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** 2026财年营收达到770万美元,同比增长107%,主要由新医院采用和强劲的客户留存率推动。第四季度营收190万美元,同比增长66%。 **盈利能力:** 毛利润实现30万美元,而上年同期亏损170万美元,实现200万美元的正向转变,标志着重要的盈利里程碑。 **净亏损:** 归属于普通股股东的净亏损为3,320万美元,每股亏损4.01美元,较上年4,660万美元亏损有所改善。 **现金流:** 净现金消耗1,910万美元,同比减少56%。截至20
06-27 12:03
Beyond Air (NASDAQ:XAIR) sees Calendar Year 2027 sales of $16.000 million-$18.000 million
06-26 19:21
Companies Reporting Before The Bell • Beyond Air (NASDAQ:XAIR) is estimated to report quarterly loss at $0.56 per share on revenue of $2.30 million. • Apogee Enterprises (NASDAQ:APOG) is expected to report quarterly earnings at $0.41 per share on revenue of $332.01 million. • Cineverse (NASDAQ:CNVS)...
06-26 19:12
Beyond Air (NASDAQ:XAIR) reported quarterly losses of $(0.77) per share which missed the analyst consensus estimate of $(0.57) by 35.09 percent. This is a 57.22 percent increase over losses of $(1.80) per share from the same period last year. The company reported quarterly sales of $1.907 million wh...
06-26 19:11
With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Apogee Enterprises Inc. (NASDAQ:APOG) to post quarterly earnings at 45 cents per share on revenue of $333.84 billion before the opening bell, accord...
06-26 14:48
An update from Beyond Air ( ($XAIR) ) is now available. On June 18, 2026, Beyon...
06-23 05:40
Beyond Air, Inc. (NASDAQ: XAIR) announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2026, on June 26, 2026. Management will host a conference call and webcast at 8:00 am ET on the same day. The call can be accessed domestically at 1-877-407-0784, internationally at 1-201-689-8560, or via webcast on the Company’s website. Beyond Air is a medical device and biopharmaceutical company focused on usin...
06-22 20:01
Beyond Air, Inc. (NASDAQ:XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that the Nasdaq Hearings
06-01 20:08
Beyond Air, Inc. has been granted by the Nasdaq Hearings Panel to continue its listing on The Nasdaq Stock Market, contingent on regaining compliance with the Bid Price Rule by July 31, 2026. The Company is compliant with all other listing requirements. CEO Robert Goodman expressed appreciation for the Panel's support and noted the decision allows time to regain compliance while advancing commercial execution and developing the next-generation po...
06-01 12:00
随着4月结束,市值20亿美元以下的小型医疗保健股空头头寸显著增加,显示市场对这类高波动性股票的看空情绪升温。 根据最新数据,5月初医疗保健板块空头比例最...
05-05 03:24